The evolution of SARS-CoV-2

被引:0
作者
Peter V. Markov
Mahan Ghafari
Martin Beer
Katrina Lythgoe
Peter Simmonds
Nikolaos I. Stilianakis
Aris Katzourakis
机构
[1] Joint Research Centre (JRC),European Commission
[2] University of London,London School of Hygiene & Tropical Medicine
[3] University of Oxford,Big Data Institute
[4] Friedrich-Loeffler-Institut,Institute of Diagnostic Virology
[5] University of Oxford,Nuffield Department of Medicine
[6] University of Erlangen–Nuremberg,Department of Biometry and Epidemiology
[7] University of Oxford,Department of Biology
来源
Nature Reviews Microbiology | 2023年 / 21卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused millions of deaths and substantial morbidity worldwide. Intense scientific effort to understand the biology of SARS-CoV-2 has resulted in daunting numbers of genomic sequences. We witnessed evolutionary events that could mostly be inferred indirectly before, such as the emergence of variants with distinct phenotypes, for example transmissibility, severity and immune evasion. This Review explores the mechanisms that generate genetic variation in SARS-CoV-2, underlying the within-host and population-level processes that underpin these events. We examine the selective forces that likely drove the evolution of higher transmissibility and, in some cases, higher severity during the first year of the pandemic and the role of antigenic evolution during the second and third years, together with the implications of immune escape and reinfections, and the increasing evidence for and potential relevance of recombination. In order to understand how major lineages, such as variants of concern (VOCs), are generated, we contrast the evidence for the chronic infection model underlying the emergence of VOCs with the possibility of an animal reservoir playing a role in SARS-CoV-2 evolution, and conclude that the former is more likely. We evaluate uncertainties and outline scenarios for the possible future evolutionary trajectories of SARS-CoV-2.
引用
收藏
页码:361 / 379
页数:18
相关论文
共 50 条
[41]   The Yin and Yang of SARS-CoV-2 Mutation and Evolution [J].
Badley, Andrew D. .
MAYO CLINIC PROCEEDINGS, 2021, 96 (04) :863-865
[42]   Mutations and Evolution of the SARS-CoV-2 Spike Protein [J].
Magazine, Nicholas ;
Zhang, Tianyi ;
Wu, Yingying ;
McGee, Michael C. ;
Veggiani, Gianluca ;
Huang, Weishan .
VIRUSES-BASEL, 2022, 14 (03)
[43]   SARS-CoV-2: tracing the origin, tracking the evolution [J].
Konstantinos Voskarides .
BMC Medical Genomics, 15
[44]   Rapid evolution of SARS-CoV-2 in domestic cats [J].
Bashor, Laura ;
Gagne, Roderick B. ;
Bosco-Lauth, Angela ;
Stenglein, Mark ;
VandeWoude, Sue .
VIRUS EVOLUTION, 2022, 8 (02)
[45]   The impact of remdesivir on SARS-CoV-2 evolution in vivo [J].
Ling-Hu, Ted ;
Simons, Lacy M. ;
Rios-Guzman, Estefany ;
Carvalho, Alexandre Machado ;
Agnes, Maria Francesca R. ;
Alisoltanidehkordi, Arghavan ;
Ozer, Egon A. ;
Lorenzo-Redondo, Ramon ;
Hultquist, Judd F. .
JCI INSIGHT, 2025, 10 (04)
[46]   Antigenic evolution of SARS-CoV-2 in immunocompromised hosts [J].
Smith, Cameron A. ;
Ashby, Ben .
EVOLUTION MEDICINE AND PUBLIC HEALTH, 2023, 11 (01) :90-100
[47]   Virtual Issue on SARS-CoV-2: Evolution of a Pandemic [J].
McGrath, Casey .
GENOME BIOLOGY AND EVOLUTION, 2023, 15 (04)
[48]   Origin, evolution and global spread of SARS-CoV-2 [J].
Zhukova, Anna ;
Blassel, Luc ;
Lemoine, Frederic ;
Morel, Marie ;
Voznica, Jakub ;
Gascuel, Olivier .
COMPTES RENDUS BIOLOGIES, 2021, 344 (01) :57-75
[49]   Evolution of Antiviral Drug Resistance in SARS-CoV-2 [J].
Dinata, Roy ;
Baindara, Piyush ;
Mandal, Santi M. .
VIRUSES-BASEL, 2025, 17 (05)
[50]   Convergent evolution of SARS-CoV-2 in human and animals [J].
Zhou, Hang-Yu ;
Ji, Cheng-Yang ;
Fan, Hang ;
Han, Na ;
Li, Xiao-Feng ;
Wu, Aiping ;
Qin, Cheng-Feng .
PROTEIN & CELL, 2021, 12 (11) :832-835